WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int;
Министерство на здравеопазването, https://www.mh.government.bg/bg/novini/aktualno/1-333-sa-novite-sluchai-na-koronavirusna-infekciya/
Xie Y, Bowe B, Maddukuri G, Al-Aly Z: Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: Cohort study. BMJ 371: m4677, 2021;
Al-Aly Z, Xie Y, Bowe B: High-dimensional characterization of post- acute sequelae of COVID-19. Nature 594: 259–264, 2021;
Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol. 2021 Feb;17(2):81-82. doi: 10.1038/s41581-020-00381-4. PMID: 33257872; PMCID: PMC7703720;
Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, Zununi Vahed S. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. 2021 May;31(3):e2176. doi: 10.1002/rmv.2176. Epub 2020 Oct 6. PMID: 33022818; PMCID: PMC7646060;
Ng JH, Hirsch JS, Hazzan A, Wanchoo R, Shah HH, Malieckal DA, et al.; Northwell Nephrology COVID-19 Research Consortium. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis 2021; 77:204–215 e1;
Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney in- jury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014; 371:58–66.;
Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al.; Mount Sinai COVID Informatics Center (MSCIC). AKI in hospitalized patients with COVID-19. J Am Soc Nephrol 2021; 32:151–60.
Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, et al.; The STOP-COVID Investigators. AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol 2021; 32:161–76;
Silver, S. A. et al. The prevalence of acute kidney injury in patients hospitalized with COVID¬19 infection: a systematic review and meta¬analysis. Kidney Med. 3, 83–98 (2021);
Nadim, M. K. et al. COVID¬19¬associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat. Rev. Nephrol. 16, 747–764 (2020).;
Hultstro ̈m M, Lipcsey M, Wallin E, Larsson I-M, Larsson A, Frithiof R. Severe acute kidney injury associated with progres- sion of chronic kidney disease after critical COVID-19. Crit Care 2021; 25:37;
Stockmann H, Hardenberg J-HB, Aigner A, Hinze C, Gotthardt I, Stier B, et al. High rates of long-term renal recovery in survi- vors of COVID-19-associated acute kidney injury requiring kidney replacement therapy. Kidney Int 2021; 99(4):1021–1022;
Xiaoying Gu,Lixue Huang,Dan Cui,Yeming Wang,Yimin Wang,Jiuyang Xu,Lianhan Shang,Guohui Fan, Bin Cao, et al. Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study, Lancet 2022;76: 103817;
Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long covid. Journal of the American Society of Nephrology. 2021;
Huang, C. et al. 6¬month consequences of COVID¬19 in patients discharged from hospital: a cohort study. Lancet 397, 220–232 (2021).
Стоянова Л., Ненова К., Димова М., Маринова Е., Динков А., Стайкова С., Съвременни биохимични маркери за ренална дисфункция , сп. Нефрология, диализа и трансплантация, бр 1/2019 г., стр 24-29;
Стоянова Л., Стайкова С., Димова М., Маринова Е., NGAL / неутрофилен гелатиназа-асоцииран липокалин /- биомаркер за ранно бъбречно увреждане и прогресия на ХБЗ, сп. Наука Кардиология, бр. 3/2018 г. стр. 103-106;
Findling, M. G., Blendon, R. J. & Benson, J. M. Delayed care with harmful health consequences — reported experiences from national surveys during coronavirus disease 2019. JAMA Health Forum 1, e201463 (2020;
PHOSP-COVID https://www.phosp.org/about/
